Product Description
Phloroglucinol Injection is used for:
-Symptomatic treatment of pain associated with functional disorders of the gastrointestinal tract and biliary tract.
- Treatment of spasmodic and painful manifestations of acute urinary tract: renal colic.
- Symptomatic treatment of painful spastic manifestations in gynaecology.
AI Product Description
*The following content is generated by AI and is for reference only.
Phloroglucinol Injection 40mg/4ml is a potent antispasmodic agent primarily utilized in the management of acute abdominal pain associated with smooth muscle spasms. This medication functions by directly relaxing the smooth muscles of the gastrointestinal tract, biliary system, and urinary tract without affecting normal peristalsis or secretory functions. It is frequently prescribed to alleviate severe colicky pains caused by conditions such as renal colic, biliary colic, irritable bowel syndrome (IBS) exacerbations, and other functional disorders involving visceral hypermotility. The intravenous formulation allows for rapid onset of action, making it particularly valuable in emergency settings where immediate relief from intense cramping is required.
The active ingredient, phloroglucinol, acts as an anticholinergic-like agent but possesses a unique mechanism that targets the smooth muscle cell membrane, reducing calcium influx and preventing contraction. Unlike traditional anticholinergics, it generally lacks significant systemic side effects related to dry mouth, blurred vision, or tachycardia when used at therapeutic doses. However, despite its favorable safety profile, specific precautions must be observed. This injection is contraindicated in patients with known hypersensitivity to phloroglucinol or any excipients within the formulation. Caution is advised in individuals with myasthenia gravis, paralytic ileus, or severe hepatic impairment, although data on these specific populations remains limited.
During administration, healthcare providers should monitor vital signs, particularly blood pressure and heart rate, as transient hypotension or bradycardia may occur rarely. Patients with a history of cardiovascular instability require careful observation. Furthermore, this product is not indicated for chronic maintenance therapy due to the nature of the injection route; it is strictly reserved for acute episodes. Pregnant and lactating women should only receive this medication if the potential benefit clearly outweighs the theoretical risk to the fetus or infant, as clinical data is insufficient. Medical professionals must ensure proper reconstitution and dilution protocols are followed to prevent local irritation at the injection site. Overall, Phloroglucinol Injection 40mg/4ml serves as an effective tool for rapid symptomatic relief of visceral spasms, provided it is administered under strict medical supervision and adhering to established clinical guidelines.